$RGNX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in REGENXBIO Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in REGENXBIO Inc.. Get notifications about new insider transactions in REGENXBIO Inc. for free.
Page: < prev 1 2 3 4 5 6 6 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 3.76 | 716 | 2,692 | 18,786 | 18.1 K to 18.8 K (+3.96 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 12.74 | 6,250 | 79,625 | 18,070 | 11.8 K to 18.1 K (+52.88 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 18.85 | 6,250 | 117,813 | 11,820 | 5.6 K to 11.8 K (+112.21 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 22.00 | 4,687 | 103,114 | 5,570 | 883 to 5.6 K (+530.80 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 49.45 | 883 | 43,664 | 883 | 0 to 883 | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 65.00 | 1,721 | 111,865 | 0 | 1.7 K to 0 (-100.00 %) | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 49.45 | 1,721 | 85,103 | 1,721 | 0 to 1.7 K | |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 64.64 | 8,620 | 557,197 | 251,000 | 259.6 K to 251 K (-3.32 %) |
| Nov 28 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 63.81 | 11,380 | 726,158 | 259,620 | 271 K to 259.6 K (-4.20 %) |
| Nov 26 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 61.92 | 6,898 | 427,124 | 271,000 | 277.9 K to 271 K (-2.48 %) |
| Nov 26 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 61.22 | 6,802 | 416,418 | 277,898 | 284.7 K to 277.9 K (-2.39 %) |
| Nov 26 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 60.09 | 1,300 | 78,117 | 284,700 | 286 K to 284.7 K (-0.45 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 3.76 | 13,500 | 50,760 | 66,500 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 12.74 | 2,988 | 38,067 | 6,250 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 22.00 | 4,688 | 103,136 | 4,687 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 12.74 | 3,262 | 41,558 | 9,238 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 18.85 | 6,250 | 117,813 | 6,250 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Option Exercise | M | 49.45 | 2,604 | 128,768 | 9,896 | ||
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 60.38 | 21,176 | 1,278,607 | 0 | 21.2 K to 0 (-100.00 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 3.76 | 13,500 | 50,760 | 21,176 | 7.7 K to 21.2 K (+175.87 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 12.74 | 2,988 | 38,067 | 7,676 | 4.7 K to 7.7 K (+63.74 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 22.00 | 4,688 | 103,136 | 4,688 | 0 to 4.7 K | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 63.53 | 600 | 38,118 | 0 | 600 to 0 (-100.00 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 62.81 | 600 | 37,686 | 600 | 1.2 K to 600 (-50.00 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Sell | S | 60.26 | 10,916 | 657,798 | 1,200 | 12.1 K to 1.2 K (-90.10 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 12.74 | 3,262 | 41,558 | 12,116 | 8.9 K to 12.1 K (+36.84 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 18.85 | 6,250 | 117,813 | 8,854 | 2.6 K to 8.9 K (+240.02 %) | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | BESHAR LUKE M | Buy | M | 49.45 | 2,604 | 128,768 | 2,604 | 0 to 2.6 K | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 20,414 | 17,352 | 61,244 | |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 63.21 | 1,100 | 69,531 | 0 | 1.1 K to 0 (-100.00 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 61.55 | 800 | 49,240 | 1,100 | 1.9 K to 1.1 K (-42.11 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 60.25 | 4,361 | 262,750 | 1,900 | 6.3 K to 1.9 K (-69.65 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 59.61 | 9,092 | 541,974 | 6,261 | 15.4 K to 6.3 K (-59.22 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 58.37 | 2,300 | 134,251 | 15,353 | 17.7 K to 15.4 K (-13.03 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 57.08 | 2,761 | 157,598 | 17,653 | 20.4 K to 17.7 K (-13.53 %) |
| Nov 21 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 20,414 | 17,352 | 20,414 | 0 to 20.4 K |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 32,882 | 723,404 | 76,101 | |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 64.71 | 15,494 | 1,002,617 | 39,500 | 55 K to 39.5 K (-28.17 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 63.64 | 6,505 | 413,978 | 54,994 | 61.5 K to 55 K (-10.58 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 62.79 | 6,883 | 432,184 | 61,499 | 68.4 K to 61.5 K (-10.07 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 61.91 | 4,000 | 247,640 | 68,382 | 72.4 K to 68.4 K (-5.53 %) |
| Nov 20 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 32,882 | 723,404 | 72,382 | 39.5 K to 72.4 K (+83.25 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 64.10 | 100 | 6,410 | 129,783 | 129.9 K to 129.8 K (-0.08 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 63.05 | 700 | 44,135 | 129,883 | 130.6 K to 129.9 K (-0.54 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 62.23 | 2,042 | 127,074 | 130,583 | 132.6 K to 130.6 K (-1.54 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 60.40 | 588 | 35,515 | 132,625 | 133.2 K to 132.6 K (-0.44 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 59.06 | 1,900 | 112,214 | 133,213 | 135.1 K to 133.2 K (-1.41 %) |
| Nov 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 58.46 | 2,170 | 126,858 | 135,113 | 137.3 K to 135.1 K (-1.58 %) |
| Nov 09 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 72.06 | 15,000 | 1,080,900 | 2,669 | 17.7 K to 2.7 K (-84.89 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 20,414 | 17,352 | 81,658 | |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 69.97 | 4,627 | 323,751 | 0 | 4.6 K to 0 (-100.00 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 69.54 | 3,854 | 268,007 | 4,627 | 8.5 K to 4.6 K (-45.44 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 68.22 | 3,700 | 252,414 | 8,481 | 12.2 K to 8.5 K (-30.38 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 67.14 | 4,820 | 323,615 | 12,181 | 17 K to 12.2 K (-28.35 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 66.26 | 3,413 | 226,145 | 17,001 | 20.4 K to 17 K (-16.72 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 20,414 | 17,352 | 20,414 | 0 to 20.4 K |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 69.92 | 4,709 | 329,253 | 306,000 | 310.7 K to 306 K (-1.52 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 69.47 | 3,340 | 232,030 | 310,709 | 314 K to 310.7 K (-1.06 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 68.27 | 3,635 | 248,161 | 314,049 | 317.7 K to 314 K (-1.14 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 67.16 | 4,816 | 323,443 | 317,684 | 322.5 K to 317.7 K (-1.49 %) |
| Nov 07 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 66.29 | 3,500 | 232,015 | 322,500 | 326 K to 322.5 K (-1.07 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 19.50 | 20,833 | 406,244 | 29,167 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 32,908 | 430,766 | 32,374 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 13.09 | 9,718 | 127,209 | 65,282 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 3.76 | 9,959 | 37,446 | 20,041 | |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 70.26 | 53,741 | 3,775,843 | 137,283 | 191 K to 137.3 K (-28.13 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 19.50 | 20,833 | 406,244 | 191,024 | 170.2 K to 191 K (+12.24 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 32,908 | 430,766 | 170,191 | 137.3 K to 170.2 K (+23.97 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 70.04 | 19,677 | 1,378,177 | 137,283 | 157 K to 137.3 K (-12.54 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 13.09 | 9,718 | 127,209 | 156,960 | 147.2 K to 157 K (+6.60 %) |
| Nov 05 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 3.76 | 9,959 | 37,446 | 147,242 | 137.3 K to 147.2 K (+7.25 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 20,414 | 17,352 | 102,072 | |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 64.42 | 100 | 6,442 | 0 | 100 to 0 (-100.00 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 63.67 | 5,446 | 346,747 | 100 | 5.5 K to 100 (-98.20 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 62.93 | 8,026 | 505,076 | 5,546 | 13.6 K to 5.5 K (-59.14 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 61.82 | 2,100 | 129,822 | 13,572 | 15.7 K to 13.6 K (-13.40 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 60.66 | 1,700 | 103,122 | 15,672 | 17.4 K to 15.7 K (-9.79 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 59.83 | 3,042 | 182,003 | 17,372 | 20.4 K to 17.4 K (-14.90 %) |
| Oct 31 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 20,414 | 17,352 | 20,414 | 0 to 20.4 K |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 5,000 | 60,500 | 58,472 | |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 62.67 | 90 | 5,640 | 17,669 | 17.8 K to 17.7 K (-0.51 %) |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 62.00 | 3,410 | 211,420 | 17,759 | 21.2 K to 17.8 K (-16.11 %) |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 61.22 | 1,500 | 91,830 | 21,169 | 22.7 K to 21.2 K (-6.62 %) |
| Oct 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 5,000 | 60,500 | 22,669 | 17.7 K to 22.7 K (+28.30 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 13.09 | 2,667 | 34,911 | 3,333 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 19.50 | 13,125 | 255,938 | 16,875 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Option Exercise | M | 22.00 | 46,517 | 1,023,374 | 108,983 | |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 2,667 | 162,287 | 39,500 | 42.2 K to 39.5 K (-6.32 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 13.09 | 2,667 | 34,911 | 42,167 | 39.5 K to 42.2 K (+6.75 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 13,125 | 798,656 | 39,500 | 52.6 K to 39.5 K (-24.94 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 19.50 | 13,125 | 255,938 | 52,625 | 39.5 K to 52.6 K (+33.23 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Sell | S | 60.85 | 46,517 | 2,830,559 | 39,500 | 86 K to 39.5 K (-54.08 %) |
| Oct 18 2018 | RGNX | REGENXBIO Inc. | Simpson Curran | SVP, Technical Oper ... | Buy | M | 22.00 | 46,517 | 1,023,374 | 86,017 | 39.5 K to 86 K (+117.76 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 10,414 | 8,852 | 122,486 | |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Option Exercise | M | 0.85 | 10,000 | 8,500 | 132,900 | |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 61.18 | 10,414 | 637,129 | 0 | 10.4 K to 0 (-100.00 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 10,414 | 8,852 | 10,414 | 0 to 10.4 K |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 60.25 | 100 | 6,025 | 0 | 100 to 0 (-100.00 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 59.54 | 7,000 | 416,780 | 100 | 7.1 K to 100 (-98.59 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Sell | S | 58.83 | 2,900 | 170,607 | 7,100 | 10 K to 7.1 K (-29.00 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Yoo Stephen | Chief Medical Offic ... | Buy | M | 0.85 | 10,000 | 8,500 | 10,000 | 0 to 10 K |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 59.59 | 5,000 | 297,950 | 137,283 | 142.3 K to 137.3 K (-3.51 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 58.93 | 2,500 | 147,325 | 142,283 | 144.8 K to 142.3 K (-1.73 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 59.55 | 5,710 | 340,031 | 326,000 | 331.7 K to 326 K (-1.72 %) |
| Oct 17 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 58.73 | 1,800 | 105,714 | 331,710 | 333.5 K to 331.7 K (-0.54 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Option Exercise | M | 20.35 | 20,000 | 407,000 | 80,000 | |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 65.60 | 216 | 14,170 | 0 | 216 to 0 (-100.00 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 64.78 | 4,000 | 259,120 | 216 | 4.2 K to 216 (-94.88 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 63.73 | 12,284 | 782,859 | 4,216 | 16.5 K to 4.2 K (-74.45 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Sell | S | 62.79 | 3,500 | 219,765 | 16,500 | 20 K to 16.5 K (-17.50 %) |
| Oct 10 2018 | RGNX | REGENXBIO Inc. | Danos Olivier | Chief Scientific Of ... | Buy | M | 20.35 | 20,000 | 407,000 | 20,000 | 0 to 20 K |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Option Exercise | M | 0.85 | 30,000 | 25,500 | 204,900 | |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Buy | M | 0.85 | 30,000 | 25,500 | 144,783 | 114.8 K to 144.8 K (+26.14 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 80.80 | 100 | 8,080 | 114,783 | 114.9 K to 114.8 K (-0.09 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 79.63 | 500 | 39,815 | 114,883 | 115.4 K to 114.9 K (-0.43 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 78.64 | 450 | 35,388 | 115,383 | 115.8 K to 115.4 K (-0.39 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 77.87 | 600 | 46,722 | 115,833 | 116.4 K to 115.8 K (-0.52 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 76.79 | 1,479 | 113,572 | 116,433 | 117.9 K to 116.4 K (-1.25 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 75.59 | 700 | 52,913 | 117,912 | 118.6 K to 117.9 K (-0.59 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 74.02 | 710 | 52,554 | 118,612 | 119.3 K to 118.6 K (-0.60 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 73.40 | 1,200 | 88,080 | 119,322 | 120.5 K to 119.3 K (-1.00 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 72.03 | 200 | 14,406 | 120,522 | 120.7 K to 120.5 K (-0.17 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 70.43 | 1,561 | 109,941 | 120,722 | 122.3 K to 120.7 K (-1.28 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 81.12 | 300 | 24,336 | 333,510 | 333.8 K to 333.5 K (-0.09 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 79.45 | 200 | 15,890 | 333,810 | 334 K to 333.8 K (-0.06 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 78.73 | 400 | 31,492 | 334,010 | 334.4 K to 334 K (-0.12 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 77.88 | 900 | 70,092 | 334,410 | 335.3 K to 334.4 K (-0.27 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 76.72 | 1,450 | 111,244 | 335,310 | 336.8 K to 335.3 K (-0.43 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 75.29 | 622 | 46,830 | 336,760 | 337.4 K to 336.8 K (-0.18 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 73.80 | 1,399 | 103,246 | 337,382 | 338.8 K to 337.4 K (-0.41 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 73.04 | 624 | 45,577 | 338,781 | 339.4 K to 338.8 K (-0.18 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 71.10 | 100 | 7,110 | 339,405 | 339.5 K to 339.4 K (-0.03 %) |
| Sep 19 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 70.46 | 1,515 | 106,747 | 339,505 | 341 K to 339.5 K (-0.44 %) |
| Aug 29 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Option Exercise | M | 0.85 | 145,000 | 123,250 | 234,670 | |
| Aug 29 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 67.02 | 1,753 | 117,486 | 341,020 | 342.8 K to 341 K (-0.51 %) |
| Aug 29 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 66.29 | 5,757 | 381,632 | 342,773 | 348.5 K to 342.8 K (-1.65 %) |
| Aug 29 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Buy | M | 0.85 | 145,000 | 123,250 | 348,530 | 203.5 K to 348.5 K (+71.24 %) |
| Aug 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Option Exercise | M | 12.10 | 5,000 | 60,500 | 63,472 | |
| Aug 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 66.41 | 1,600 | 106,256 | 17,669 | 19.3 K to 17.7 K (-8.30 %) |
| Aug 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Sell | S | 65.75 | 3,400 | 223,550 | 19,269 | 22.7 K to 19.3 K (-15.00 %) |
| Aug 22 2018 | RGNX | REGENXBIO Inc. | Christmas Patrick J. | SVP, General Counse ... | Buy | M | 12.10 | 5,000 | 60,500 | 22,669 | 17.7 K to 22.7 K (+28.30 %) |
| Aug 17 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 65.99 | 1,301 | 85,853 | 122,283 | 123.6 K to 122.3 K (-1.05 %) |
| Aug 17 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 65.31 | 6,199 | 404,857 | 123,584 | 129.8 K to 123.6 K (-4.78 %) |
| Jul 18 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 77.88 | 1,500 | 116,820 | 129,783 | 131.3 K to 129.8 K (-1.14 %) |
| Jul 18 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 76.60 | 862 | 66,029 | 131,283 | 132.1 K to 131.3 K (-0.65 %) |
| Jul 18 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 75.18 | 2,510 | 188,702 | 132,145 | 134.7 K to 132.1 K (-1.86 %) |
| Jul 18 2018 | RGNX | REGENXBIO Inc. | Vasista Vittal | Chief Financial Off ... | Sell | S | 74.19 | 2,628 | 194,971 | 134,655 | 137.3 K to 134.7 K (-1.91 %) |
| Jun 22 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 67.66 | 750 | 50,745 | 203,530 | 204.3 K to 203.5 K (-0.37 %) |
| Jun 22 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 66.59 | 2,650 | 176,464 | 204,280 | 206.9 K to 204.3 K (-1.28 %) |
| Jun 22 2018 | RGNX | REGENXBIO Inc. | Mills Kenneth T. | President and CEO | Sell | S | 65.48 | 1,300 | 85,124 | 206,930 | 208.2 K to 206.9 K (-0.62 %) |